Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association

被引:408
作者
Buse, John B.
Ginsberg, Henry N.
Bakris, George L.
Clark, Nathaniel G.
Costa, Fernando
Eckel, Robert
Fonseca, Vivian
Gerstein, Hertzel C.
Grundy, Scott
Nesto, Richard W.
Pignone, Michael P.
Plutzky, Jorge
Porte, Daniel
Redberg, Rita
Stitzel, Kimberly F.
Stone, Neil J.
机构
关键词
AHA Scientific Statement; cardiovascular diseases; diabetes mellitus; primary prevention;
D O I
10.1161/CIRCULATIONAHA.106.179294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for cardiovascular disease prevention: The ADA has issued separate recommendations for each of the cardiovascular risk factors in patients with diabetes, and the AHA has shaped primary and secondary guidelines that extend to patients with diabetes. This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 83 条
[51]   Seventh report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC 7) resetting the hypertension sails [J].
Lenfant, C ;
Chobanian, AV ;
Jones, DW ;
Roccella, EJ .
HYPERTENSION, 2003, 41 (06) :1178-1179
[52]  
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[53]   Nutrients and cardiovascular disease: no easy answers [J].
Lichtenstein, AH .
CURRENT OPINION IN LIPIDOLOGY, 2005, 16 (01) :1-3
[55]   Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes - Results of the HOPE study and MICRO-HOPE substudy [J].
Lonn, E ;
Yusuf, S ;
Hoogwerf, B ;
Pogue, J ;
Yi, QL ;
Zinman, B ;
Bosch, J ;
Dagenais, G ;
Mann, JFE ;
Gerstein, HC .
DIABETES CARE, 2002, 25 (11) :1919-1927
[56]   Diabetes and all-cause and coronary heart disease mortality among US male physicians [J].
Lotufo, PA ;
Gaziano, JM ;
Chae, CU ;
Ajani, UA ;
Moreno-John, G ;
Buring, JE ;
Manson, JE .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (02) :242-247
[57]   Predicting vascular risk in Type 1 diabetes: stratification in a hospital based population in Scotland [J].
McKnight, J ;
Belch, J ;
Campbell, I ;
Carmichael, C ;
Chalmers, J ;
Chalmers, L ;
Connacher, A ;
Doig, J ;
Dow, E ;
Ferguson, M ;
Fowle, M ;
Fraser, D ;
Gold, A ;
Gray, S ;
Hanning, I ;
Hawthorne, V ;
Holliday, M ;
Jennings, P ;
Jung, R ;
Leese, G ;
Lewis, S ;
MacDonald, M ;
MacLeod, M ;
Matthews, D ;
McBain, A ;
McCullough, D ;
McEwan, S ;
McKnight, J ;
Morris, A ;
Newton, R ;
Patrick, A ;
Peden, N ;
Prescott, R ;
Reith, S ;
Roger, J ;
Scott, M ;
Siann, T ;
Smith, A ;
Thompson, C ;
Walker, J ;
Williamson, J .
DIABETIC MEDICINE, 2005, 22 (02) :164-171
[58]   Fish oil supplementation in type 2 diabetes - A quantitative systematic review [J].
Montori, VM ;
Farmer, A ;
Wollan, PC ;
Dinneen, SF .
DIABETES CARE, 2000, 23 (09) :1407-1415
[59]   Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores [J].
Mora, S ;
Redberg, RF ;
Sharrett, AR ;
Blumenthal, RS .
CIRCULATION, 2005, 112 (11) :1566-1572
[60]   Lifetime risk for diabetes mellitus in the United States [J].
Narayan, KMV ;
Boyle, JP ;
Thompson, TJ ;
Sorensen, SW ;
Williamson, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (14) :1884-1890